Prosperity Capital Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
22,286
+4,798
| +27% | +$98.4K | 0.04% | 185 |
|
|
2025
Q1 | $349K | Buy |
17,488
+3,085
| +21% | +$61.6K | 0.03% | 274 |
|
|
2024
Q4 | $326K | Sell |
14,403
-288
| -2% | -$6.52K | 0.03% | 271 |
|
|
2024
Q3 | $362K | Buy |
14,691
+1,058
| +8% | +$26K | 0.03% | 249 |
|
|
2024
Q2 | $315K | Buy |
13,633
+1,792
| +15% | +$41.4K | 0.03% | 240 |
|
|
2024
Q1 | $285K | Buy |
11,841
+182
| +2% | +$4.38K | 0.03% | 271 |
|
|
2023
Q4 | $268K | Buy |
+11,659
| New | +$268K | 0.03% | 210 |
|